HAO vs BIDU

For growth investors, Haoxi Health Technology Limited (HAO) is the stronger pick with 71.

9% revenue growth year-over-year, versus -1. 1% for Baidu, Inc. (BIDU). Haoxi Health Technology Limited (HAO) offers the better valuation at 0. 6x trailing P/E, making it the more compelling value choice. Analysts rate Baidu, Inc. (BIDU) a "Buy" — based on 53 analyst ratings — the highest consensus in this comparison. The "better buy" depends entirely on your goals: growth investors should weight revenue trajectory, value investors should weight P/E and PEG, and income investors should weight dividend yield and streak.

On trailing P/E, Haoxi Health Technology Limited (HAO) is the cheapest at 0.

6x versus Baidu, Inc. at 14. 5x.

Over the past 5 years, Baidu, Inc.

(BIDU) delivered a total return of -26. 9%, compared to -99. 5% for Haoxi Health Technology Limited (HAO). Over 10 years, the gap is even starker: BIDU returned -19. 2% versus HAO's -96. 7%. Past returns do not guarantee future results, and the stock with the higher historical return may already have its best growth priced in.

By beta (market sensitivity over 5 years), Haoxi Health Technology Limited (HAO) is the lower-risk stock at 0.

65β versus Baidu, Inc. 's 1. 41β — meaning BIDU is approximately 118% more volatile than HAO relative to the S&P 500. On balance sheet safety, Haoxi Health Technology Limited (HAO) carries a lower debt/equity ratio of 11% versus 28% for Baidu, Inc. — giving it more financial flexibility in a downturn.

By revenue growth (latest reported year), Haoxi Health Technology Limited (HAO) is pulling ahead at 71.

9% versus -1. 1% for Baidu, Inc. (BIDU). On earnings-per-share growth, the picture is similar: Haoxi Health Technology Limited grew EPS 1105% year-over-year, compared to 19. 6% for Baidu, Inc.. Over a 3-year CAGR, HAO leads at 55. 7% annualised revenue growth. Higher growth typically commands a higher valuation multiple — check whether the premium P/E or P/S is justified by the growth rate using the PEG ratio.

Baidu, Inc.

(BIDU) is the more profitable company, earning 17. 8% net margin versus 2. 7% for Haoxi Health Technology Limited — meaning it keeps 17. 8% of every revenue dollar as bottom-line profit. Operating margin tells a similar story: BIDU leads at 16. 0% versus 3. 5% for HAO. At the gross margin level — before operating expenses — BIDU leads at 50. 3%, reflecting greater pricing power or product mix advantage. Stronger margins indicate durable pricing power, lower cost of revenue, or higher mix of software/services. They are one of the clearest signs of business quality.

None of the stocks in this comparison currently pay a material dividend.

All are effectively zero-yield and should be held for capital appreciation rather than income.

For long-horizon retirement investors, Haoxi Health Technology Limited (HAO) is the stronger choice — it scores higher on the combination of lower volatility, dividend reliability, and long-term compounding (low volatility (β 0.

65)). Both have compounded well over 10 years (HAO: -96. 7%, BIDU: -19. 2%), confirming both are viable long-term holds — but the lower-volatility option typically results in less emotional selling during corrections. Retirement portfolios generally favour predictability over maximum returns. Consult a financial advisor before making allocation decisions.

Both stocks operate in the Communication Services sector, making this a peer-level intra-sector comparison — the same macro tailwinds and headwinds will affect both.

In terms of investment character: HAO is a small-cap high-growth stock; BIDU is a mid-cap deep-value stock. These fundamental differences mean investors should not choose between them on a single metric — the "better stock" depends entirely on which of these characteristics aligns with your investment strategy.